Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

China Pharma Holdings Operating Margin 2010-2023 | CPHI

Current and historical operating margin for China Pharma Holdings (CPHI) over the last 10 years. The current operating profit margin for China Pharma Holdings as of December 31, 2023 is -43.91%.
  
China Pharma Holdings Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2023-12-31 $0.01B $-0.00B -28.57%
2023-09-30 $0.01B $-0.00B -25.00%
2023-06-30 $0.01B $-0.00B -25.00%
2023-03-31 $0.01B $-0.00B -33.33%
2022-12-31 $0.01B $-0.00B -44.44%
2022-09-30 $0.01B $-0.00B -44.44%
2022-06-30 $0.01B $-0.00B -44.44%
2022-03-31 $0.01B $-0.00B -44.44%
2021-12-31 $0.01B $-0.00B -44.44%
2021-09-30 $0.01B $-0.00B -44.44%
2021-06-30 $0.01B $-0.00B -44.44%
2021-03-31 $0.01B $-0.00B -27.27%
2020-12-31 $0.01B $-0.00B -27.27%
2020-09-30 $0.01B $-0.02B -190.91%
2020-06-30 $0.01B $-0.02B -190.91%
2020-03-31 $0.01B $-0.02B -220.00%
2019-12-31 $0.01B $-0.02B -190.91%
2019-09-30 $0.01B $-0.01B -90.91%
2019-06-30 $0.01B $-0.01B -100.00%
2019-03-31 $0.01B $-0.01B -100.00%
2018-12-31 $0.01B $-0.01B -91.67%
2018-09-30 $0.01B $-0.02B -130.77%
2018-06-30 $0.01B $-0.02B -121.43%
2018-03-31 $0.01B $-0.02B -128.57%
2017-12-31 $0.01B $-0.02B -146.15%
2017-09-30 $0.01B $-0.01B -57.14%
2017-06-30 $0.01B $-0.01B -57.14%
2017-03-31 $0.02B $-0.01B -53.33%
2016-12-31 $0.02B $-0.01B -50.00%
2016-09-30 $0.02B $-0.02B -125.00%
2016-06-30 $0.02B $-0.02B -88.24%
2016-03-31 $0.02B $-0.01B -63.16%
2015-12-31 $0.02B $-0.02B -71.43%
2015-09-30 $0.02B $-0.02B -115.79%
2015-06-30 $0.02B $-0.03B -147.62%
2015-03-31 $0.02B $-0.04B -195.24%
2014-12-31 $0.02B $-0.04B -177.27%
2014-09-30 $0.03B $-0.03B -92.59%
2014-06-30 $0.03B $-0.02B -75.86%
2014-03-31 $0.03B $-0.02B -58.06%
2013-12-31 $0.03B $-0.02B -59.38%
2013-09-30 $0.04B $-0.01B -33.33%
2013-06-30 $0.04B $-0.01B -17.50%
2013-03-31 $0.05B 0 0.00%
2012-12-31 $0.06B $0.01B 10.91%
2012-09-30 $0.07B $0.01B 18.46%
2012-06-30 $0.07B $0.02B 21.62%
2012-03-31 $0.08B $0.02B 25.32%
2011-12-31 $0.08B $0.02B 27.16%
2011-09-30 $0.08B $0.03B 30.12%
2011-06-30 $0.08B $0.03B 30.86%
2011-03-31 $0.08B $0.02B 30.77%
2010-12-31 $0.08B $0.02B 32.00%
2010-09-30 $0.07B $0.02B 30.99%
2010-06-30 $0.07B $0.02B 35.29%
2010-03-31 $0.07B $0.02B 36.92%
2009-12-31 $0.06B $0.02B 36.51%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.005B $0.007B
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $15.751B 5.69
Dr Reddy's Laboratories (RDY) India $12.261B 19.39
Aspen Pharmacare (APNHY) South Africa $5.328B 0.00
BridgeBio Pharma (BBIO) United States $4.794B 0.00
Bausch Health Cos (BHC) Canada $3.201B 2.50
Amphastar Pharmaceuticals (AMPH) United States $2.016B 13.80
Supernus Pharmaceuticals (SUPN) United States $1.655B 0.00
Taysha Gene Therapies (TSHA) United States $0.454B 0.00
Generation Bio (GBIO) United States $0.188B 0.00
Personalis (PSNL) United States $0.074B 0.00
Assembly Biosciences (ASMB) United States $0.068B 0.00
Acasti Pharma (ACST) Canada $0.026B 0.00
Sol-Gel Technologies (SLGL) Israel $0.020B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00